News & events


September 27, 2017 11:00am EST

Metrics that Matter: A Guide to Imaging Measurements in Oncology Clinical Trials

Presented by: Fabien Ricard, MD, Medical Director and Catherine Klifa, PhD, Science Liaison

Medical imaging is an integral component of clinical trials in oncology. For each image type, quantifiable information (biomarkers) can be extracted and analyzed to potentially answer questions about tumor types and stage, and to measure any sign of response to treatment. The most common assessment of response to therapy is to measure anatomical changes to the tumor with treatment. Other quantitative imaging measures derived from functional imaging methods provide equally important physiological information about a tumor, including tumor metabolism, vascularity, and cellularity.

What you will learn in this webinar:
– The difference between qualitative and quantitative biomarkers
– Definition of treatment response criteria
– Various types of measurement: morphological and volumetric
– Functional imaging measurements by modality
– Measurements by cancer/treatment type

See all webinars

Press releases

See all press releases


November 28  -29, 2017 Amsterdam, The Netherlands

Partnerships in Clinical Trials - Europe

Median will be participating in the Partnerships in Clinical Trials – Europe conference November 28  -29 in Amsterdam, The Netherlands.

Visit conference website here.

Visit conference website
See all conferences

In the press

Global career strategies for the 21st century

About the importance of understanding cultural differences in Business – According to Jeanne Hecht, COO at Median Technologies, “Working around the globe requires self-awareness, a knowledge of other cultures and, more importantly, building real connections”. Read the full article here

Source: UNC KENAN-FLAGLER website, date of publication: May 17, 2017

See all in the press


See all blog entries

Cookies help us deliver our services. By using our services, you agree to our use of cookies.